М. Маркова и Г. Христов, „Reporting of R&D Costs Under IAS 38 – The Case of Biopharmaceutical Companies“, НТ, бр. 4, стр. 57–65, Яну 2023, doi: https://doi.org/10.37075/RP.2022.4.04.